glp 1 pen tirzepatida GLP-1s appear to cut cancer risk. Researchers are asking why and how : NPR glp 1 pen tirzepatida Q&A:

Witkiewitz, K

GIP enhances insulin secretion in a glucose-dependent manner, meaning it boosts insulin release when blood sugar is elevated but does not push insulin levels dangerously low when blood sugar is normal

The Statistics: Who Is Using These Medications 1 in 8 Americans reported using a GLP-1 medication as of 2025 (Gallup National Health and Well-Being Index, 2025) 12.4% of Americans reported GLP-1 use in late 2025 more than double the 5.8% reported in February 2024 40 million+ GLP-1 prescriptions were written in the United States in 2024 alone Approximately 63% of patients who began Wegovy or Zepbound in early 2024 remained on therapy one year later, up from 40% among the 2023 cohort

Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy

Theres a lot of bureaucracy in hiring

Acids 31 , 211223 (2023)